IGC Pharma, Inc. (IGC)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.4501 |
| Open | 0.4620 |
| Bid | 0.4401 x 1300 |
| Ask | 0.4525 x 1100 |
| Day's range | 0.4410 - 0.4623 |
| 52-week range | 0.2500 - 0.9100 |
| Volume | |
| Avg. volume | 320,567 |
| Market cap | 33.961M |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2200 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.38 |
Business WireIGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target
POTOMAC, Md., July 18, 2024--IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target
Business WirePreclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile
POTOMAC, Md., July 09, 2024--Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile
Business WireIGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease
POTOMAC, Md., June 25, 2024--IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease
© 2024 Yahoo. All rights reserved.